• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三尖瓣和二尖瓣瓣缘对缘修复的综合机构学习经验。

Institutional learning experience for combined edge-to-edge tricuspid and mitral valve repair.

机构信息

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

出版信息

Catheter Cardiovasc Interv. 2020 Nov;96(6):1323-1330. doi: 10.1002/ccd.28856. Epub 2020 Mar 17.

DOI:10.1002/ccd.28856
PMID:32180349
Abstract

BACKGROUND

Transcatheter edge-to-edge repair with MitraClip is only approved for treatment of mitral regurgitation but is increasingly used to treat concomitant tricuspid regurgitation (TR) due to its common coexistence and association with poor outcomes. This study aimed to describe the learning curve associated with the challenge of off-label treatment of concomitant TR.

METHODS

This is a retrospective review of initial and consecutive patients who underwent combined edge-to-edge repair of mitral and tricuspid valves (TVs) at our institution from August 2017 to October 2019.

RESULTS

Repair of both valves with MitraClip was performed in 22 patients (median age 81.5 years, 32% female). Mean procedure time was 176 ± 47 min; mean fluoroscopy time was 65 ± 24 min. Procedure duration in the first tertile was significantly longer (223 ± 13 min) than in the third tertile (143 ± 23 min, p = .0003). Median number of total clips placed per case was 3; in 15 patients (68%), the anterior and septal leaflets of the TV were clipped. The average changes in mean right atrial (RA) and left atrial (LA) pressures were -1.7 ± 2.5 mmHg (p = .0080) and -3.2 ± 4.6 mmHg (p = .0045), respectively. The average changes in RA and LA V-wave heights were -3.3 ± 4.0 mmHg (p = .0009) and -8.1 ± 9.9 mmHg (p = .038), respectively. There was a significant trend toward decreasing residual TR over the course of the series (p = .046). At 30 days, survival was 100% and mean NYHA class decreased from 2.8 to 1.8 (p < .0001).

CONCLUSIONS

Combined edge-to-edge tricuspid and mitral valve repair is safe and feasible. With experience, procedure duration and residual TR decreased.

摘要

背景

经导管缘对缘修复术(MitraClip)仅被批准用于治疗二尖瓣反流,但由于其共同存在并与不良预后相关,越来越多地用于治疗同时存在的三尖瓣反流(TR)。本研究旨在描述与同时治疗 TR 的挑战性相关的学习曲线。

方法

这是对 2017 年 8 月至 2019 年 10 月期间在我院接受二尖瓣和三尖瓣(TV)联合缘对缘修复的初始和连续患者的回顾性研究。

结果

22 例患者(中位年龄 81.5 岁,32%为女性)接受了 MitraClip 治疗。平均手术时间为 176±47 分钟;平均透视时间为 65±24 分钟。第 1 三分位的手术时间明显长于第 3 三分位(223±13 分钟比 143±23 分钟,p =.0003)。每例患者放置的总夹数量中位数为 3 个;在 15 例患者(68%)中,TV 的前叶和隔叶被夹闭。平均右心房(RA)和左心房(LA)压力的变化分别为-1.7±2.5mmHg(p =.0080)和-3.2±4.6mmHg(p =.0045)。RA 和 LA V 波高度的平均变化分别为-3.3±4.0mmHg(p =.0009)和-8.1±9.9mmHg(p =.038)。随着研究的进行,残余 TR 呈显著下降趋势(p =.046)。30 天时,存活率为 100%,NYHA 分级平均从 2.8 级降至 1.8 级(p<.0001)。

结论

联合缘对缘三尖瓣和二尖瓣修复是安全可行的。随着经验的积累,手术时间和残余 TR 减少。

相似文献

1
Institutional learning experience for combined edge-to-edge tricuspid and mitral valve repair.三尖瓣和二尖瓣瓣缘对缘修复的综合机构学习经验。
Catheter Cardiovasc Interv. 2020 Nov;96(6):1323-1330. doi: 10.1002/ccd.28856. Epub 2020 Mar 17.
2
Combined Tricuspid and Mitral Versus Isolated Mitral Valve Repair for Severe MR and TR: An Analysis From the TriValve and TRAMI Registries.三尖瓣和二尖瓣联合修复与单纯二尖瓣修复治疗重度 MR 和 TR:来自 TriValve 和 TRAMI 注册研究的分析。
JACC Cardiovasc Interv. 2020 Mar 9;13(5):543-550. doi: 10.1016/j.jcin.2019.10.023. Epub 2020 Jan 15.
3
Combined Mitral and Tricuspid Versus Isolated Mitral Valve Transcatheter Edge-to-Edge Repair in Patients With Symptomatic Valve Regurgitation at High Surgical Risk.高手术风险的有症状瓣膜反流患者的二尖瓣和三尖瓣联合瓣 versus 单纯二尖瓣瓣环成形术。
JACC Cardiovasc Interv. 2018 Jun 25;11(12):1142-1151. doi: 10.1016/j.jcin.2018.04.010.
4
Predictors of Procedural and Clinical Outcomes in Patients With Symptomatic Tricuspid Regurgitation Undergoing Transcatheter Edge-to-Edge Repair.经导管缘对缘修复术治疗症状性三尖瓣反流患者的操作和临床结局的预测因素。
JACC Cardiovasc Interv. 2018 Jun 25;11(12):1119-1128. doi: 10.1016/j.jcin.2018.05.002.
5
Outcomes of ring versus suture annuloplasty for tricuspid valve repair in patients undergoing mitral valve surgery.环扎与缝线瓣环成形术治疗二尖瓣手术中三尖瓣修复的结果。
J Thorac Cardiovasc Surg. 2016 Aug;152(2):406-415.e3. doi: 10.1016/j.jtcvs.2016.04.068. Epub 2016 May 3.
6
Tricuspid Valve Repair for the Poor Right Ventricle: Tricuspid Valve Repair in Patients with Mild-to-Moderate Tricuspid Regurgitation Undergoing Mitral Valve Repair Improves In-Hospital Outcome.针对右心室功能不佳的三尖瓣修复:二尖瓣修复术中轻至中度三尖瓣反流患者的三尖瓣修复可改善住院结局。
Thorac Cardiovasc Surg. 2017 Dec;65(8):612-616. doi: 10.1055/s-0034-1399783. Epub 2015 Jan 28.
7
First-in-Human Report of MitraClip G4 Implantation for Torrential Tricuspid Regurgitation and Severe Secondary Mitral Regurgitation.经导管二尖瓣夹合术(MitraClip)G4植入治疗重度三尖瓣反流及重度继发性二尖瓣反流的首例人体报告
JACC Cardiovasc Interv. 2020 Jul 13;13(13):1599-1602. doi: 10.1016/j.jcin.2020.02.034. Epub 2020 Apr 15.
8
Impact of preinterventional tricuspid regurgitation on outcome of MitraClip therapy in patients with severely reduced ejection fraction.介入治疗前三尖瓣反流对射血分数严重降低患者MitraClip治疗结局的影响。
Open Heart. 2020 Mar 15;7(1):e001203. doi: 10.1136/openhrt-2019-001203. eCollection 2020.
9
1-Year Outcomes After Edge-to-Edge Valve Repair for Symptomatic Tricuspid Regurgitation: Results From the TriValve Registry.Edge-to-Edge 瓣叶修复术治疗症状性三尖瓣反流的 1 年结果:TriValve 注册研究结果。
JACC Cardiovasc Interv. 2019 Aug 12;12(15):1451-1461. doi: 10.1016/j.jcin.2019.04.019.
10
Reduction in Right Atrial Pressures Is Associated With Hemodynamic Improvements After Transcatheter Edge-to-Edge Repair of the Tricuspid Valve.经导管缘对缘修复三尖瓣后右心房压力降低与血液动力学改善相关。
Circ Cardiovasc Interv. 2021 Dec;14(12):e010557. doi: 10.1161/CIRCINTERVENTIONS.121.010557. Epub 2021 Nov 24.

引用本文的文献

1
Transcatheter Tricuspid Valve Intervention: Current Perspective.经导管三尖瓣介入治疗:当前观点
US Cardiol. 2021 Jun 30;15:e12. doi: 10.15420/usc.2020.26. eCollection 2021.
2
A Practical Approach to Combined Transcatheter Mitral and Tricuspid Valve Intervention.经导管二尖瓣和三尖瓣联合介入治疗的实用方法。
Front Cardiovasc Med. 2021 Oct 13;8:706123. doi: 10.3389/fcvm.2021.706123. eCollection 2021.
3
Determinants of Morbidity and Mortality Associated With Isolated Tricuspid Valve Surgery.孤立性三尖瓣手术相关发病率和死亡率的决定因素。
J Am Heart Assoc. 2021 Jan 19;10(2):e018417. doi: 10.1161/JAHA.120.018417. Epub 2021 Jan 5.